What is the projected market valuation of the Endoscopic Submucosal Dissection Market by 2035?

The projected market valuation for the Endoscopic Submucosal Dissection Market is expected to reach approximately 0.8998 USD Billion by 2035. Read More

What was the market valuation of the Endoscopic Submucosal Dissection Market in 2024?

The overall market valuation for the Endoscopic Submucosal Dissection Market was 0.42 USD Billion in 2024. Read More

What is the expected CAGR for the Endoscopic Submucosal Dissection Market during the forecast period 2025 - 2035?

The expected CAGR for the Endoscopic Submucosal Dissection Market during the forecast period 2025 - 2035 is 7.17%. Read More

Which companies are considered key players in the Endoscopic Submucosal Dissection Market?

Key players in the Endoscopic Submucosal Dissection Market include Olympus Corporation, Fujifilm Holdings Corporation, Medtronic plc, and Boston Scientific Corporation. Read More

What are the projected revenues for Endoscopic Submucosal Dissection with Triangulation by 2035?

The projected revenue for Endoscopic Submucosal Dissection with Triangulation is expected to reach 0.32 USD Billion by 2035. Read More

What is the expected revenue for Endoscopic Submucosal Dissection with Mucosal Flap Technique by 2035?

The expected revenue for Endoscopic Submucosal Dissection with Mucosal Flap Technique is projected to be 0.34 USD Billion by 2035. Read More

What treatment indications are driving growth in the Endoscopic Submucosal Dissection Market?

Treatment indications such as benign gastric lesions and cancer lesions are driving growth, with projected revenues of 0.25 USD Billion and 0.20 USD Billion respectively by 2035. Read More

Which endoscopic technology is anticipated to have the highest revenue by 2035?

Flexible Endoscopy is anticipated to have the highest revenue, projected to reach 0.35 USD Billion by 2035. Read More

What is the revenue outlook for High-Definition Endoscopes in the Endoscopic Submucosal Dissection Market?

The revenue outlook for High-Definition Endoscopes is expected to grow from 0.15 USD Billion in 2024 to 0.35 USD Billion by 2035. Read More

Endoscopic Submucosal Dissection Market

Q: How do revenues for Endoscopic Submucosal Dissection with Circumferential Incision compare from 2024 to 2035?

Revenues for Endoscopic Submucosal Dissection with Circumferential Incision increased from 0.12 USD Billion in 2024 to a projected 0.25 USD Billion by 2035. Read More

ID: MRFR/HC/25537-HCR

128 Pages

Nidhi Mandole

Last Updated: April 06, 2026

Endoscopic Submucosal Dissection Market Research Report By Procedure Type (Endoscopic Submucosal Dissection with Triangulation, Endoscopic Submucosal Dissection with Circumferential Incision, Endoscopic Submucosal Dissection with Mucosal Flap Technique), By Treatment Indication (Benign Esophageal Lesions, Benign Gastric Lesions, Benign Colorectal Lesions, Cancer Lesions), By Equipment Type (High-Definition Endoscope, Standard Endoscope, Single-Operator Endoscope, Multi-Operator Endoscope), By Endoscopic Technology (Narrow Band Imaging, Flexible Endoscopy, Confocal Endomicroscopy, Optical Coherence Tomography) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Endoscopic Submucosal Dissection Market Infographic

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1.1 EXECUTIVE SUMMARY
1.1.1 Market Overview
1.1.2 Key Findings
1.1.3 Market Segmentation
1.1.4 Competitive Landscape
1.1.5 Challenges and Opportunities
1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
2.1 MARKET INTRODUCTION
2.1.1 Definition
2.1.2 Scope of the study
2.1.2.1 Research Objective
2.1.2.2 Assumption
2.1.2.3 Limitations
2.2 RESEARCH METHODOLOGY
2.2.1 Overview
2.2.2 Data Mining
2.2.3 Secondary Research
2.2.4 Primary Research
2.2.4.1 Primary Interviews and Information Gathering Process
2.2.4.2 Breakdown of Primary Respondents
2.2.5 Forecasting Model
2.2.6 Market Size Estimation
2.2.6.1 Bottom-Up Approach
2.2.6.2 Top-Down Approach
2.2.7 Data Triangulation
2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
3.1 MARKET DYNAMICS
3.1.1 Overview
3.1.2 Drivers
3.1.3 Restraints
3.1.4 Opportunities
3.2 MARKET FACTOR ANALYSIS
3.2.1 Value chain Analysis
3.2.2 Porter's Five Forces Analysis
3.2.2.1 Bargaining Power of Suppliers
3.2.2.2 Bargaining Power of Buyers
3.2.2.3 Threat of New Entrants
3.2.2.4 Threat of Substitutes
3.2.2.5 Intensity of Rivalry
3.2.3 COVID-19 Impact Analysis
3.2.3.1 Market Impact Analysis
3.2.3.2 Regional Impact
3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
4.1 Healthcare, BY Procedure Type (USD Billion)
4.1.1 Endoscopic Submucosal Dissection with Triangulation
4.1.2 Endoscopic Submucosal Dissection with Circumferential Incision
4.1.3 Endoscopic Submucosal Dissection with Mucosal Flap Technique
4.2 Healthcare, BY Treatment Indication (USD Billion)
4.2.1 Benign Esophageal Lesions
4.2.2 Benign Gastric Lesions
4.2.3 Benign Colorectal Lesions
4.2.4 Cancer Lesions
4.3 Healthcare, BY Equipment Type (USD Billion)
4.3.1 High-Definition Endoscope
4.3.2 Standard Endoscope
4.3.3 Single-Operator Endoscope
4.3.4 Multi-Operator Endoscope
4.4 Healthcare, BY Endoscopic Technology (USD Billion)
4.4.1 Narrow Band Imaging
4.4.2 Flexible Endoscopy
4.4.3 Confocal Endomicroscopy
4.4.4 Optical Coherence Tomography
4.5 Healthcare, BY Region (USD Billion)
4.5.1 North America
4.5.1.1 US
4.5.1.2 Canada
4.5.2 Europe
4.5.2.1 Germany
4.5.2.2 UK
4.5.2.3 France
4.5.2.4 Russia
4.5.2.5 Italy
4.5.2.6 Spain
4.5.2.7 Rest of Europe
4.5.3 APAC
4.5.3.1 China
4.5.3.2 India
4.5.3.3 Japan
4.5.3.4 South Korea
4.5.3.5 Malaysia
4.5.3.6 Thailand
4.5.3.7 Indonesia
4.5.3.8 Rest of APAC
4.5.4 South America
4.5.4.1 Brazil
4.5.4.2 Mexico
4.5.4.3 Argentina
4.5.4.4 Rest of South America
4.5.5 MEA
4.5.5.1 GCC Countries
4.5.5.2 South Africa
4.5.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
5.1 Competitive Landscape
5.1.1 Overview
5.1.2 Competitive Analysis
5.1.3 Market share Analysis
5.1.4 Major Growth Strategy in the Healthcare
5.1.5 Competitive Benchmarking
5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
5.1.7 Key developments and growth strategies
5.1.7.1 New Product Launch/Service Deployment
5.1.7.2 Merger & Acquisitions
5.1.7.3 Joint Ventures
5.1.8 Major Players Financial Matrix
5.1.8.1 Sales and Operating Income
5.1.8.2 Major Players R&D Expenditure. 2023
5.2 Company Profiles
5.2.1 Olympus Corporation (JP)
5.2.1.1 Financial Overview
5.2.1.2 Products Offered
5.2.1.3 Key Developments
5.2.1.4 SWOT Analysis
5.2.1.5 Key Strategies
5.2.2 Fujifilm Holdings Corporation (JP)
5.2.2.1 Financial Overview
5.2.2.2 Products Offered
5.2.2.3 Key Developments
5.2.2.4 SWOT Analysis
5.2.2.5 Key Strategies
5.2.3 Medtronic plc (IE)
5.2.3.1 Financial Overview
5.2.3.2 Products Offered
5.2.3.3 Key Developments
5.2.3.4 SWOT Analysis
5.2.3.5 Key Strategies
5.2.4 Boston Scientific Corporation (US)
5.2.4.1 Financial Overview
5.2.4.2 Products Offered
5.2.4.3 Key Developments
5.2.4.4 SWOT Analysis
5.2.4.5 Key Strategies
5.2.5 Cook Medical LLC (US)
5.2.5.1 Financial Overview
5.2.5.2 Products Offered
5.2.5.3 Key Developments
5.2.5.4 SWOT Analysis
5.2.5.5 Key Strategies
5.2.6 Conmed Corporation (US)
5.2.6.1 Financial Overview
5.2.6.2 Products Offered
5.2.6.3 Key Developments
5.2.6.4 SWOT Analysis
5.2.6.5 Key Strategies
5.2.7 Hoya Corporation (JP)
5.2.7.1 Financial Overview
5.2.7.2 Products Offered
5.2.7.3 Key Developments
5.2.7.4 SWOT Analysis
5.2.7.5 Key Strategies
5.2.8 Stryker Corporation (US)
5.2.8.1 Financial Overview
5.2.8.2 Products Offered
5.2.8.3 Key Developments
5.2.8.4 SWOT Analysis
5.2.8.5 Key Strategies
5.2.9 EndoChoice, Inc. (US)
5.2.9.1 Financial Overview
5.2.9.2 Products Offered
5.2.9.3 Key Developments
5.2.9.4 SWOT Analysis
5.2.9.5 Key Strategies
5.3 Appendix
5.3.1 References
5.3.2 Related Reports
6 LIST OF FIGURES
6.1 MARKET SYNOPSIS
6.2 NORTH AMERICA MARKET ANALYSIS
6.3 US MARKET ANALYSIS BY PROCEDURE TYPE
6.4 US MARKET ANALYSIS BY TREATMENT INDICATION
6.5 US MARKET ANALYSIS BY EQUIPMENT TYPE
6.6 US MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
6.7 CANADA MARKET ANALYSIS BY PROCEDURE TYPE
6.8 CANADA MARKET ANALYSIS BY TREATMENT INDICATION
6.9 CANADA MARKET ANALYSIS BY EQUIPMENT TYPE
6.10 CANADA MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
6.11 EUROPE MARKET ANALYSIS
6.12 GERMANY MARKET ANALYSIS BY PROCEDURE TYPE
6.13 GERMANY MARKET ANALYSIS BY TREATMENT INDICATION
6.14 GERMANY MARKET ANALYSIS BY EQUIPMENT TYPE
6.15 GERMANY MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
6.16 UK MARKET ANALYSIS BY PROCEDURE TYPE
6.17 UK MARKET ANALYSIS BY TREATMENT INDICATION
6.18 UK MARKET ANALYSIS BY EQUIPMENT TYPE
6.19 UK MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
6.20 FRANCE MARKET ANALYSIS BY PROCEDURE TYPE
6.21 FRANCE MARKET ANALYSIS BY TREATMENT INDICATION
6.22 FRANCE MARKET ANALYSIS BY EQUIPMENT TYPE
6.23 FRANCE MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
6.24 RUSSIA MARKET ANALYSIS BY PROCEDURE TYPE
6.25 RUSSIA MARKET ANALYSIS BY TREATMENT INDICATION
6.26 RUSSIA MARKET ANALYSIS BY EQUIPMENT TYPE
6.27 RUSSIA MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
6.28 ITALY MARKET ANALYSIS BY PROCEDURE TYPE
6.29 ITALY MARKET ANALYSIS BY TREATMENT INDICATION
6.30 ITALY MARKET ANALYSIS BY EQUIPMENT TYPE
6.31 ITALY MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
6.32 SPAIN MARKET ANALYSIS BY PROCEDURE TYPE
6.33 SPAIN MARKET ANALYSIS BY TREATMENT INDICATION
6.34 SPAIN MARKET ANALYSIS BY EQUIPMENT TYPE
6.35 SPAIN MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
6.36 REST OF EUROPE MARKET ANALYSIS BY PROCEDURE TYPE
6.37 REST OF EUROPE MARKET ANALYSIS BY TREATMENT INDICATION
6.38 REST OF EUROPE MARKET ANALYSIS BY EQUIPMENT TYPE
6.39 REST OF EUROPE MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
6.40 APAC MARKET ANALYSIS
6.41 CHINA MARKET ANALYSIS BY PROCEDURE TYPE
6.42 CHINA MARKET ANALYSIS BY TREATMENT INDICATION
6.43 CHINA MARKET ANALYSIS BY EQUIPMENT TYPE
6.44 CHINA MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
6.45 INDIA MARKET ANALYSIS BY PROCEDURE TYPE
6.46 INDIA MARKET ANALYSIS BY TREATMENT INDICATION
6.47 INDIA MARKET ANALYSIS BY EQUIPMENT TYPE
6.48 INDIA MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
6.49 JAPAN MARKET ANALYSIS BY PROCEDURE TYPE
6.50 JAPAN MARKET ANALYSIS BY TREATMENT INDICATION
6.51 JAPAN MARKET ANALYSIS BY EQUIPMENT TYPE
6.52 JAPAN MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
6.53 SOUTH KOREA MARKET ANALYSIS BY PROCEDURE TYPE
6.54 SOUTH KOREA MARKET ANALYSIS BY TREATMENT INDICATION
6.55 SOUTH KOREA MARKET ANALYSIS BY EQUIPMENT TYPE
6.56 SOUTH KOREA MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
6.57 MALAYSIA MARKET ANALYSIS BY PROCEDURE TYPE
6.58 MALAYSIA MARKET ANALYSIS BY TREATMENT INDICATION
6.59 MALAYSIA MARKET ANALYSIS BY EQUIPMENT TYPE
6.60 MALAYSIA MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
6.61 THAILAND MARKET ANALYSIS BY PROCEDURE TYPE
6.62 THAILAND MARKET ANALYSIS BY TREATMENT INDICATION
6.63 THAILAND MARKET ANALYSIS BY EQUIPMENT TYPE
6.64 THAILAND MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
6.65 INDONESIA MARKET ANALYSIS BY PROCEDURE TYPE
6.66 INDONESIA MARKET ANALYSIS BY TREATMENT INDICATION
6.67 INDONESIA MARKET ANALYSIS BY EQUIPMENT TYPE
6.68 INDONESIA MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
6.69 REST OF APAC MARKET ANALYSIS BY PROCEDURE TYPE
6.70 REST OF APAC MARKET ANALYSIS BY TREATMENT INDICATION
6.71 REST OF APAC MARKET ANALYSIS BY EQUIPMENT TYPE
6.72 REST OF APAC MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
6.73 SOUTH AMERICA MARKET ANALYSIS
6.74 BRAZIL MARKET ANALYSIS BY PROCEDURE TYPE
6.75 BRAZIL MARKET ANALYSIS BY TREATMENT INDICATION
6.76 BRAZIL MARKET ANALYSIS BY EQUIPMENT TYPE
6.77 BRAZIL MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
6.78 MEXICO MARKET ANALYSIS BY PROCEDURE TYPE
6.79 MEXICO MARKET ANALYSIS BY TREATMENT INDICATION
6.80 MEXICO MARKET ANALYSIS BY EQUIPMENT TYPE
6.81 MEXICO MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
6.82 ARGENTINA MARKET ANALYSIS BY PROCEDURE TYPE
6.83 ARGENTINA MARKET ANALYSIS BY TREATMENT INDICATION
6.84 ARGENTINA MARKET ANALYSIS BY EQUIPMENT TYPE
6.85 ARGENTINA MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY PROCEDURE TYPE
6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY TREATMENT INDICATION
6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY EQUIPMENT TYPE
6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
6.90 MEA MARKET ANALYSIS
6.91 GCC COUNTRIES MARKET ANALYSIS BY PROCEDURE TYPE
6.92 GCC COUNTRIES MARKET ANALYSIS BY TREATMENT INDICATION
6.93 GCC COUNTRIES MARKET ANALYSIS BY EQUIPMENT TYPE
6.94 GCC COUNTRIES MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
6.95 SOUTH AFRICA MARKET ANALYSIS BY PROCEDURE TYPE
6.96 SOUTH AFRICA MARKET ANALYSIS BY TREATMENT INDICATION
6.97 SOUTH AFRICA MARKET ANALYSIS BY EQUIPMENT TYPE
6.98 SOUTH AFRICA MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
6.99 REST OF MEA MARKET ANALYSIS BY PROCEDURE TYPE
6.100 REST OF MEA MARKET ANALYSIS BY TREATMENT INDICATION
6.101 REST OF MEA MARKET ANALYSIS BY EQUIPMENT TYPE
6.102 REST OF MEA MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
6.103 KEY BUYING CRITERIA OF HEALTHCARE
6.104 RESEARCH PROCESS OF MRFR
6.105 DRO ANALYSIS OF HEALTHCARE
6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
6.109 HEALTHCARE, BY PROCEDURE TYPE, 2024 (% SHARE)
6.110 HEALTHCARE, BY PROCEDURE TYPE, 2024 TO 2035 (USD Billion)
6.111 HEALTHCARE, BY TREATMENT INDICATION, 2024 (% SHARE)
6.112 HEALTHCARE, BY TREATMENT INDICATION, 2024 TO 2035 (USD Billion)
6.113 HEALTHCARE, BY EQUIPMENT TYPE, 2024 (% SHARE)
6.114 HEALTHCARE, BY EQUIPMENT TYPE, 2024 TO 2035 (USD Billion)
6.115 HEALTHCARE, BY ENDOSCOPIC TECHNOLOGY, 2024 (% SHARE)
6.116 HEALTHCARE, BY ENDOSCOPIC TECHNOLOGY, 2024 TO 2035 (USD Billion)
6.117 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
7.1 LIST OF ASSUMPTIONS
7.1.1
7.2 North America MARKET SIZE ESTIMATES; FORECAST
7.2.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.2.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
7.2.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.2.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
7.3 US MARKET SIZE ESTIMATES; FORECAST
7.3.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.3.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
7.3.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.3.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
7.4 Canada MARKET SIZE ESTIMATES; FORECAST
7.4.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.4.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
7.4.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.4.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
7.5 Europe MARKET SIZE ESTIMATES; FORECAST
7.5.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.5.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
7.5.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.5.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
7.6 Germany MARKET SIZE ESTIMATES; FORECAST
7.6.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.6.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
7.6.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.6.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
7.7 UK MARKET SIZE ESTIMATES; FORECAST
7.7.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.7.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
7.7.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.7.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
7.8 France MARKET SIZE ESTIMATES; FORECAST
7.8.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.8.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
7.8.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.8.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
7.9 Russia MARKET SIZE ESTIMATES; FORECAST
7.9.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.9.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
7.9.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.9.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
7.10 Italy MARKET SIZE ESTIMATES; FORECAST
7.10.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.10.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
7.10.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.10.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
7.11 Spain MARKET SIZE ESTIMATES; FORECAST
7.11.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.11.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
7.11.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.11.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
7.12.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.12.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
7.12.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.12.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
7.13 APAC MARKET SIZE ESTIMATES; FORECAST
7.13.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.13.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
7.13.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.13.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
7.14 China MARKET SIZE ESTIMATES; FORECAST
7.14.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.14.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
7.14.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.14.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
7.15 India MARKET SIZE ESTIMATES; FORECAST
7.15.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.15.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
7.15.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.15.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
7.16 Japan MARKET SIZE ESTIMATES; FORECAST
7.16.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.16.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
7.16.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.16.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
7.17.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.17.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
7.17.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.17.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
7.18.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.18.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
7.18.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.18.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
7.19.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.19.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
7.19.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.19.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
7.20.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.20.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
7.20.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.20.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
7.21.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.21.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
7.21.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.21.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
7.22 South America MARKET SIZE ESTIMATES; FORECAST
7.22.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.22.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
7.22.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.22.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
7.23.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.23.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
7.23.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.23.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
7.24.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.24.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
7.24.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.24.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
7.25.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.25.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
7.25.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.25.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
7.26.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.26.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
7.26.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.26.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
7.27 MEA MARKET SIZE ESTIMATES; FORECAST
7.27.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.27.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
7.27.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.27.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
7.28.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.28.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
7.28.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.28.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
7.29.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.29.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
7.29.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.29.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
7.30.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
7.30.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
7.30.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.30.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Healthcare Market Segmentation

Healthcare By Procedure Type (USD Billion, 2025-2035)

Endoscopic Submucosal Dissection with Triangulation
Endoscopic Submucosal Dissection with Circumferential Incision
Endoscopic Submucosal Dissection with Mucosal Flap Technique

Healthcare By Treatment Indication (USD Billion, 2025-2035)

Benign Esophageal Lesions
Benign Gastric Lesions
Benign Colorectal Lesions
Cancer Lesions

Healthcare By Equipment Type (USD Billion, 2025-2035)

High-Definition Endoscope
Standard Endoscope
Single-Operator Endoscope
Multi-Operator Endoscope

Healthcare By Endoscopic Technology (USD Billion, 2025-2035)

Narrow Band Imaging
Flexible Endoscopy
Confocal Endomicroscopy
Optical Coherence Tomography

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓